Intero Biosystems
ActiveMiniature Human Organs for Preclinical Drug Development.
What it does
Intero Biosystems is a pioneering health company specializing in the development of miniature organs for preclinical testing. Addressing the high failure rate of drugs in clinical trials, Intero Biosystems has created the first stem cell-derived human "mini gut" that replicates the cell types, spatial structure, and function of the human intestine. Their flagship product, GastroScreen, features the intestinal lining, functional smooth muscle for peristalsis, perfusable blood vessels, and responsive neurons—forming a complete mini-organ "in a dish." GastroScreen is a valuable tool for drug testing, disease modeling, and functional assessments of critical organ functions, enabling customers to mitigate risks and identify safer, more effective compounds before human trials. Intero Biosystems' innovative approach revolutionizes preclinical testing, offering a more accurate and reliable model for predicting human outcomes.
Its site says now · captured 2026-08-23
Intero Biosystems | Miniature Organs for Preclinical Testing
Building complex human organoids for reliable preclinical testing. Discover how biology-first innovation drives faster, better drug development.
Next to it in Healthcare and bio · Miniature organs for drug testing
- PolybiomicsPlug and Play PnP 2025
Polybiomics enables simultaneous measurements of multiple cellular features from the same sample in real-time.
- 10x ScienceY Combinator W26
The AI-native platform for next-generation protein characterization.
- Radicle SciencePlug and Play PnP 2025
Radicle Science is a health tech trailblazer bringing clinical proof to natural products and wellness. Its proof-as-a-service platform combines AI, clinical trials, and crowdsourcing to generate rigorous data on the effects of wellness products on diverse populations—at unprecedented scale and speed
- Great Bay Bio 大湾生物Plug and Play PnP 2025
By utilizing AI and other cutting-edge technologies, GBB aims to address the challenges of long timelines, high costs, and low success rates in drug development.
- Atlas DiscoveryY Combinator S26
Predicting human response to drugs in clinical trials
- Elnora AI, Inc.Plug and Play PnP 2025
Elnora is an AI co-pilot for biomedical lab protocols that learns from every experiment to accelerate drug discovery.
- CytodymeTechstars TS 2025
Cytodyme
- DARERL ApSPlug and Play PnP 2024
Digital twins for testing medical devices